Cover Image
市場調查報告書

阿茲海默症治療藥的全球市場:產業分析、規模、佔有率、成長、趨勢、預測

Alzheimer's Drugs Market (Drug class - Cholinergic, Memantine, and Combined Drug; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 552209
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
阿茲海默症治療藥的全球市場:產業分析、規模、佔有率、成長、趨勢、預測 Alzheimer's Drugs Market (Drug class - Cholinergic, Memantine, and Combined Drug; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2017年08月09日 內容資訊: 英文 175 Pages
簡介

本報告提供全球阿茲海默症治療藥市場調查,市場概要,市場成長的各種影響因素及市場機會分析,各藥物類別、流通管道、地區、主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 序章

第2章 前提條件、調查手法

第3章 摘要整理

第4章 市場概要

  • 市場概要
  • 全球阿茲海默症治療藥市場規模預測
  • 阿茲海默症治療藥市場展望
  • 主要的產業活動

第5章 市場動態

  • 促進要素、抑制因素分析
  • 促進要素
  • 抑制因素
  • 機會
  • 趨勢
  • 波特的五力分析
  • PEST分析
  • 開發平台分析
  • 全球盛行率 & 發病率
  • 生物標記分析
  • 最有前景的分子

第6章 阿茲海默症治療藥市場分析:各類藥物

  • 主要調查結果
  • 簡介
  • 全球阿茲海默症治療藥市場佔有率分析 (以金額為準) :各類藥物
  • 全球阿茲海默症治療藥市場預測:各類藥物
  • 全球阿茲海默症治療藥市場分析:各類藥物
  • 全球阿茲海默症治療藥市場魅力度分析:各類藥物
  • 主要趨勢

第7章 阿茲海默症治療藥市場分析:各流通管道

  • 主要調查結果
  • 簡介
  • 全球阿茲海默症治療藥市場佔有率分析 (以金額為準) :各流通管道
  • 全球阿茲海默症治療藥市場預測:各流通管道
  • 全球阿茲海默症治療藥市場分析:各流通管道
  • 全球阿茲海默症治療藥市場魅力度分析:各流通管道
  • 主要趨勢

第8章 阿茲海默症治療藥市場分析:各地區

  • 全球阿茲海默症治療藥市場概要:各國
  • 全球阿茲海默症治療藥市場佔有率分析 (以金額為準) :各地區
  • 全球阿茲海默症治療藥市場預測:各地區
  • 全球阿茲海默症治療藥市場魅力度分析:各地區

第9章 北美的阿茲海默症治療藥市場分析

  • 市場概要
  • 北美的阿茲海默症治療藥市場概要
  • 北美的阿茲海默症治療藥市場佔有率分析 (以金額為準) :各類藥物
  • 北美的阿茲海默症治療藥市場佔有率分析 (以金額為準) :各流通管道
  • 北美的阿茲海默症治療藥市場預測:各流通管道
  • 北美的阿茲海默症治療藥市場佔有率分析 (以金額為準) :各國
  • 北美的阿茲海默症治療藥市場預測:各國
  • 北美的阿茲海默症治療藥市場魅力分析
  • 主要趨勢

第10章 歐洲的阿茲海默症治療藥市場分析

第11章 亞太地區的阿茲海默症治療藥市場分析

第12章 南美的阿茲海默症治療藥市場分析

第13章 中東、非洲的阿茲海默症治療藥市場分析

第14章 企業簡介

  • 阿茲海默症的市場佔有率分析:各企業
  • 競爭矩陣
  • 企業簡介
    • Allergan plc
    • Novartis AG
    • Eisai
    • Johnson & Johnson
    • 第一三共
    • 小野藥品工業
    • H Lundbeck A/S
    • Merz Holding GmbH & Co KG

圖表清單

目錄

Global Alzheimer's Drugs Market: Overview

This report on the Alzheimer's drugs market analyzes the current and future scenario of the global market. Increasing prevalence of Alzheimer's, innovation in the development of new drugs, biomarker analysis and most promising molecules analysis, drug class sales during the forecast period.

Global Alzheimer's Drugs Market: Research Methodology

The global Alzheimer's drugs market report contain an elaborate executive summary, which includes following points such as market snapshot that provides information about various segments globally. It also comprise information and data analysis of the country's market with respect to the segments based on drug class type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises PEST Analysis, Porters Five Forces Analysis and Pipeline Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Alzheimer's drug market.

Global Alzheimer's Drugs Market: Segmentation

Based on drug class, the market has been segmented into four major drug class such as cholinergic, memantine, combined drugs, and others. The market segments have been analyzed based on available approved products, cost-effectiveness. All segments market size and forecast has been presented for the period from 2017 to 2025, 2016 consider as a base year for this report.

As per distribution channels, the global Alzheimer's drugs market has been segmented into three segments including hospital pharmacy, retail pharmacy, and online sales. All market segmentations has been analyzed based on increasing demand for disease treatment. Increased patient hospitalization for the treatment of Alzheimer's are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also comprise the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, Alzheimer's drugs market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been presented for the period from 2015 to 2025. CAGR for all segments has been presented for the period from 2017 to 2025, 2016 consider as a base year for this report.

Global Alzheimer's Drugs Market: Competitive Dynamics

The report also profiles major key players in the Alzheimer's drugs market based on various attributes such as company overview, product portfolio, financial overview, business strategies, recent developments and company SWOT analysis. Major players operating in the Alzheimer's drug market included in this report are Allergan plc, Novartis AG, Eisai Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Merz Holding GmbH & Co KG, and Johnson & Johnson.

Global Alzheimer's Drugs Market is segmented as below:

Global Alzheimer's Drug Market, by Drug Class

  • Cholinergic
  • Memantine
  • Combined Drug
  • Others

Global Alzheimer's Drug Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Global Alzheimer's Drug Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1: Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

Chapter 2: Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

Chapter 3: Executive Summary

  • 3.1. Alzheimer's Drugs Market Snapshot, 2016
  • 3.2. Alzheimer's Drugs Market: Opportunity Map

Chapter 4: Market Overview

  • 4.1. Introduction
  • 4.2. Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • 4.3. Alzheimer's Drugs Market Outlook
  • 4.4. Key Industry Events

Chapter 5: Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
    • 5.2.1. Increasing global prevalence of Alzheimer's
    • 5.2.2. Improvising regulatory scenario
    • 5.2.3. Increasing government funding
    • 5.2.4. Entry of novel symptomatic therapies
    • 5.2.5. Growing social awareness of the disease
  • 5.3. Restraints
    • 5.3.1. Alzheimer's drug failure rate at 99%
    • 5.3.2. Multifactorial etiology and complex pathophysiology of the disease
    • 5.3.3. High level of comorbidity occurring in the elderly population
    • 5.3.4. Expanding diagnostic capability
    • 5.3.5. Increasing cost for Alzheimer's drug development
  • 5.4. Opportunities
    • 5.4.1. Reduce the time and risk of AD drug development through an improvement in trial design
    • 5.4.2. Improving clinical outcomes
  • 5.5. Trends
    • 5.5.1. Development of compounds acting on the main stages of the pathogenesis of the disease (disease-modifying agents
    • 5.5.2. Focused design of multi targeted drugs acting on multiple molecular targets involved in the pathogenesis of the disease
  • 5.6. Porter's Five Forces Analysis
  • 5.7. PEST Analysis
  • 5.8. Pipeline Analysis
  • 5.9. Global Prevalence & Incidence
  • 5.10. Biomarkers Analysis
  • 5.11. Most Promising Molecules

Chapter 6: Alzheimer's Drugs Market Analysis by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Alzheimer's Drugs Market Value Share Analysis, by Drug Class
  • 6.4. Global Alzheimer's Drugs Market Forecast, by Drug Class
  • 6.5. Global Alzheimer's Drugs Market Analysis, by Drug Class
  • 6.6. Global Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class
  • 6.7. Key Trends

Chapter 7: Alzheimer's Drugs Market Analysis, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Global Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel
  • 7.4. Global Alzheimer's Drugs Market Forecast, by Distribution Channel
  • 7.5. Global Alzheimer's Drugs Market Analysis, by Distribution Channel
  • 7.6. Global Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel
  • 7.7. Key Trends

Chapter 8: Alzheimer's Drugs Market Analysis by Region

  • 8.1. Global Alzheimer's Drugs Market Snapshot, by Country
  • 8.2. Global Alzheimer's Drugs Market Value Share Analysis, by Region
  • 8.3. Global Alzheimer's Drugs Market Forecast, by Region
  • 8.4. Global Alzheimer's Drugs Market Attractiveness, by Region

Chapter 9: North America Alzheimer's Drugs Market Analysis

  • 9.1. Key Findings
  • 9.2. North America Alzheimer's Drugs Market Overview
  • 9.3. North America Alzheimer's Drugs Market Value Share Analysis, by Drug Class
  • 9.4. North America Alzheimer's Drugs Market Forecast, by Drug Class
  • 9.5. North America Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel
  • 9.6. North America Alzheimer's Drugs Market Forecast, by Distribution Channel
  • 9.7. North America Alzheimer's Drugs Market Value Share Analysis, by Country
  • 9.8. North America Alzheimer's Drugs Market Forecast, by Country
  • 9.9. North America Alzheimer's Drugs Market Attractiveness Analysis
  • 9.10. Market Trends

Chapter 10: Europe Alzheimer's Drugs Market Analysis

  • 10.1. Key Findings
  • 10.2. Europe Alzheimer's Drugs Market Overview
  • 10.3. Europe Alzheimer's Drugs Market Value Share Analysis, by Drug Class
  • 10.4. Europe Alzheimer's Drugs Market Forecast, by Drug Class
  • 10.5. Europe Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel
  • 10.6. Europe Alzheimer's Drugs Market Forecast, by Distribution Channel
  • 10.7. Europe Alzheimer's Drugs Market Value Share Analysis, by Country
  • 10.8. Europe Alzheimer's Drugs Market Forecast, by Country
  • 10.9. Europe Alzheimer's Drugs Market Attractiveness Analysis
  • 10.10. Market Trends

Chapter 11: Asia Pacific Alzheimer's Drugs Market Analysis

  • 11.1. Key Findings
  • 11.2. Asia Pacific Alzheimer's Drugs Market Overview
  • 11.3. Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Drug Class
  • 11.4. Asia Pacific Alzheimer's Drugs Market Forecast, by Drug Class
  • 11.5. Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel
  • 11.6. Asia Pacific Alzheimer's Drugs Market Forecast, by Distribution Channel
  • 11.7. Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Country
  • 11.8. Asia Pacific Alzheimer's Drugs Market Forecast, by Country
  • 11.9. Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis
  • 11.10. Market Trends

Chapter 12: Latin America Alzheimer's Drugs Market Analysis

  • 12.1. Key Findings
  • 12.2. Latin America Alzheimer's Drugs Market Overview
  • 12.3. Latin America Alzheimer's Drugs Market Value Share Analysis, by Drug Class
  • 12.4. Latin America Alzheimer's Drugs Market Forecast, by Drug Class
  • 12.5. Latin America Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel
  • 12.6. Latin America Alzheimer's Drugs Market Forecast, by Distribution Channel
  • 12.7. Latin America Alzheimer's Drugs Market Value Share Analysis, by Country
  • 12.8. Latin America Alzheimer's Drugs Market Forecast, by Country
  • 12.9. Latin America Alzheimer's Drugs Market Attractiveness Analysis
  • 12.10. Market Trends

Chapter 13: Middle East and Africa (MEA) Alzheimer's Drugs Market Analysis

  • 13.1. Key Findings
  • 13.2. Middle East and Africa Alzheimer's Drugs Market Overview
  • 13.3. Middle East and Africa Alzheimer's Drugs Market Value Share Analysis, by Drug Class
  • 13.4. Middle East and Africa Alzheimer's Drugs Market Forecast, by Drug Class
  • 13.5. Middle East and Africa Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel
  • 13.6. Middle East and Africa Alzheimer's Drugs Market Forecast, by Distribution Channel
  • 13.7. Middle East and Africa Alzheimer's Drugs Market Value Share Analysis, by Country
  • 13.8. Middle East and Africa Alzheimer's Drugs Market Forecast, by Country
  • 13.9. Middle East and Africa Alzheimer's Drugs Market Attractiveness Analysis
  • 13.10. Market Trends

Chapter 14: Company Profiles

  • 14.1. Alzheimer's Market Share Analysis By Company
  • 14.2. Competition Matrix
  • 14.3. Company Profiles
    • 14.3.1. Allergan plc
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Novartis AG
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Eisai Co Ltd
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Johnson & Johnson
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Daiichi Sankyo Company Limited
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Ono Pharmaceutical Co Ltd
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. H Lundbeck A/S
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Merz Holding GmbH & Co KG
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview

List of Tables

  • Table 1: Alzheimer's Drugs: Pipeline Analysis - Phase III
  • Table 2: Alzheimer's Drugs: Pipeline Analysis - Phase II
  • Table 3: Alzheimer's Drugs: Pipeline Analysis - Phase I
  • Table 4: Prevalence and Incidence by Global and Region
  • Table 5: Prevalence by Country and Region
  • Table 6: Biomarker Analysis List in Alzheimer's Drug Market
  • Table 7: Most Promising Molecules List
  • Table 8: Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 9: Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 10: Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 11: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 12: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 13: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 14: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 15: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 16: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 17: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 18: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 19: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 20: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 21: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 22: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 23: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 24: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 25: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2015-2025

List of Figures

  • Figure 1: Alzheimer's Drugs Market Snapshot, 2016
  • Figure 2: DROT Executive Summary
  • Figure 3: Market Share Executive Summary
  • Figure 4: Drug Class Revenue Share, 2016
  • Figure 5: Distribution Channel Revenue Share, 2016
  • Figure 6: Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 7: Market Value Share, by Drug Class (2016
  • Figure 8: Market Value Share, by Distribution Channel (2016)
  • Figure 9: Market Value Share, by Region (2016)
  • Figure 10: Key Industry Events
  • Figure 11: Global Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 12: Global Cholinergic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 13: Global Memantine Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 14: Global Combined Drug Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 15: Global Others Drug Class Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 16: Global Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 17: Global Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 18: Global Hospital Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 19: Global Retail Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 20: Global Online Sales Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 21: Global Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 22: Global Alzheimer's Drugs Market Value Share, by Region, 2017 and 2025
  • Figure 23: Global Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2017-2025
  • Figure 24: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 25: North America Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 26: North America Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 27: North America Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 28: North America Alzheimer's Drugs Market Value Share, by Country, 2017 and 2025
  • Figure 29: North America Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 30: North America Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 31: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 32: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 33: Europe Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 34: Europe Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 35: Europe Alzheimer's Drugs Market Value Share, by Country, 2017 and 2025
  • Figure 36: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 37: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 38: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 39: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 40: Asia Pacific Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 41: Asia Pacific Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 42: Asia Pacific Alzheimer's Drugs Market Value Share, by Country, 2017 and 2025
  • Figure 43: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 44: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 45: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 46: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 47: Latin America Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 48: Latin America Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 49: Latin America Alzheimer's Drugs Market Value Share, by Country, 2017 and 2025
  • Figure 50: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 51: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 52: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 53: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 54: Middle East & Africa Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 55: Middle East & Africa Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 56: Middle East & Africa Alzheimer's Drugs Market Value Share, by Country, 2017 and 2025
  • Figure 57: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 58: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 59: Global Alzheimer's Market Share Analysis By Company (2016)
  • Figure 60: Allergan plc Breakdown of Net Sales (%), by Business Segment, 2016
  • Figure 61: Allergan plc Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 62: Novartis Breakdown of Net Sales, by Business segments, 2016
  • Figure 63: Novartis Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 64: Eisai Breakdown of Net Sales, by Region, 2016
  • Figure 65: Eisai Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 66: Johnson Breakdown of Net Sales, by Region, 2016
  • Figure 67: Johnson Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 68: Daiichi Breakdown of Net Sales, by Region, 2016
  • Figure 69: Daiichi Revenue (US$; Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 70: Ono Breakdown of Net Sales, by Region, 2016
  • Figure 71: Ono Revenue (US$; Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 72: Lundbeck Breakdown of Net Sales, by Region 2016
  • Figure 73: Lundbeck Revenue (US$; Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 74: Merz Breakdown of Net Sales, by Region 2016
  • Figure 75: Merz Revenue (US$; Mn) & Y-o-Y Growth (%), 2013-2016
Back to Top